Steven Nissen

Steven Nissen

Get to know Steven Nissen, the cardiologist who raised worries about Vioxx and Avandia.

Sorted by: Top Picks
Written by Tony on
This CNN article has some background on Steven Nissen and his background as a politically active college student in the 1960s. Nissen has become one of the most famous whistleblowers in the medical field -- raising awareness of health risks associated with Vioxx and Avandia. The article is an interesting read. Linked from http://www.cnn.com/2005/HEALTH/11/01/profile.cardiologist.nissen/index.html --- A glimpse into his background explains a lot. As an undergraduate during the turbulent 1960s at the University of Michigan, he was "on the eight-year plan," a long road to graduation, with a minor in the antiwar movement. "A political leader, really," he described himself, "and I was also ... Read Full Story
Written by Tony on
Steven Nissen has sparked serious medical debates about the safety and viability of both Vioxx and Avandia -- two of the hottest medical debates of the year. Time magazine has named him as one of the most influential people of the year, Here's a brief excerpt and link to the main Time article. Linked from http://www.time.com/time/specials/2007/time100/article/0,28804,1595326_1595329_1616143,00.html --- Nissen, 58, a heart specialist at the Cleveland Clinic, started his climb to medical prominence in 1987 when he recognized that newer ultrasound imaging devices could be miniaturized and threaded into the beating heart to reveal the exact composition of plaques representing the early stages of artery ... Read Full Story
Written by Tony on
Wikizines are interactive magazines that anyone can create or edit - and this one is called "Steven Nissen". Here you can find fresh voices and respond in real time. Some members write articles about recent news and trends related to the wikizine's topic, others recount relevant personal stories or share their favorite pictures and video clips. Got an interesting idea or story to share with other members of this wikizine? Well, then put on your journalist's cap and add your own article! Read Full Story
Sorted by: Top Rated

Steve Nissen

Steve Nissen

Linked from: time.com

Editable by Any Member
Photo

Nissen, Steven, M.D.
Chairman, Department of Cardiovascular Medicine
Immediate Past President, American College of Cardiology, Washington, DC

Phone: (216) 445-6852
appointed:1992
medical school:University of Michigan Medical School Ann Arbor, MI
specialty training:Fellowship - University of Kentucky Chandler Medical Center Lexington KY
Internship - University of California Davis Medical Center Sacramento CA
Residency - University of California Davis Medical Center Sacramento CA
other education:B.S. - University of Michigan Ann Arbor MI
specialty interests:intravascular ultrasound, digital angiography and computer image processing, coronary intensive care

Source: Cleveland Clinic
Evidence of cardiovascular risks associated with taking Vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, Merck & Co. Inc., voluntarily pulled the drug from the market, according to new data.  
From ivanhoe.com ()
Related news:
More perspectives...
We have long been writing about the links between Merck’s blockbuster nonsteroidal, anti-inflammatory medication Vioxx (rofecoxib) and negative cardiac events. Now, according to Science Daily, a study has found that evidence of cardiovascular risks linked to Vioxx might have been realized almost four years before Merck & Co. Inc., pulled the drug from the market. Vioxx [...]  
From personalinjurylawnews.com ()
Related news:
More perspectives...
The risks of taking anti-inflammatory drug Vioxx could have been detected nearly four years before the drug was pulled from the market, according to analysis of nearly 30 clinical trials.The findings, published in the Archives of Internal Medicine on Monday, analyzed 30 Vioxx trials involving around 20,000 individuals and fund evidence of the drug's risks from as early as 2000.The Merck-made drug was pulled in 2004 after it was linked with...  
From france24.com ()
Related news:
More perspectives...
It's been 5 years since the then CEO of giant drug-maker Merck, Raymond Gilmartin, testified to the US Senate Finance Committee regarding evidence showing that Vioxx increases the risk of death due to heart attacks, strokes and other cardiovascular events. In a Summary of Prepared Testimony, Gilmartin stated that prior to the APPROVe trial (a study looking at the protective effects of Vioxx on the risk for colon cancer), the research done by...  
From z.about.com ()
Related news:
More perspectives...
CHICAGO (Reuters) - Heart risks from taking Merck & Co Inc's painkiller Vioxx could have been detected more than three years before the company withdrew the drug from the market in September 2004, had the data been openly available, U.S. researchers said on Monday.  
From reuters.com ()
Related news:
More perspectives...
AbbottAUSTIN (Legal Newsline)-A Texas judge has dismissed a lawsuit brought by the state attorney general against drugmaker Merck & Co. over its now-withdrawn painkiller Vioxx.In a 2005 lawsuit, Texas Attorney General Greg Abbott had sought a refund on behalf of the state for money spent on the drug. The lawsuit also sought damages and penalties for alleged violations of the Texas Medicaid Fraud Prevention Act.Travis County Judge Scott...  
From feedburner.com ()
Related news:
More perspectives...
WHITEHOUSE STATION, N.J. (AP) — Merck & Co. said Monday a district court judge in Texas dismissed all claims in a state Medicaid lawsuit over the painkiller Vioxx.Merck said Travis County, Texas District Court Judge Scott H. Jenkins granted the company's motion for summa....  
From dailyreportonline.com ()
Related news:
More perspectives...
Editable by Any Member
If we're missing a great Steven Nissen quoye, please add it by clicking on "edit"

Steven Nissen Quotes:

“The idea that you would see such a huge benefit so quickly is hard to accept.”

“We could still be wrong. That's what has to happen for this drug to move forward.”

“This panel was asleep at the switch.”

“There's only one way: through good science.”

“Physicians ought to take this into account. These drugs are not very forgiving.”

Sponsors
Sorted by: Top Rated
  1
  3
  4
  5
More From Zimbio
Copyright © 2009 - Zimbio, Inc. Some rights reserved.